Stenting versus Medical Treatment for Severe Symptomatic Intracranial Stenosis

References

1. 1.↵
   1. Suri MF,
   2. Johnston SC

   . Epidemiology of intracranial stenosis. J Neuroimaging 2009;19(suppl 1):11S–16S

   CrossRefPubMed
2. 2.↵
   1. Kasner SE

   . Natural history of symptomatic intracranial arterial stenosis. J Neuroimaging 2009;19(suppl 1):20S–21S

   CrossRefPubMed
3. 3.↵
   1. Chimowitz MI,
   2. Lynn MJ,
   3. Howlett-Smith H,
   4. et al

   . Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305–16

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Kasner SE,
   2. Chimowitz MI,
   3. Lynn MJ,
   4. et al

   . Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006;113:555–63

   Abstract/FREE Full Text
5. 5.↵
   1. Qureshi AI

   . Endovascular treatment of cerebrovascular diseases and intracranial neoplasms. Lancet 2004;363:804–13

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Derdeyn CP,
   2. Chimowitz MI

   . Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial. Neuroimaging Clin N Am 2007;17:355–63, viii-ix

   CrossRefPubMed
7. 7.↵
   1. Groschel K,
   2. Schnaudigel S,
   3. Pilgram SM,
   4. et al

   . A systematic review on outcome after stenting for intracranial atherosclerosis. Stroke 2009;40:e340–47

   Abstract/FREE Full Text
8. 8.↵
   1. Cruz-Flores S,
   2. Diamond AL

   . Angioplasty for intracranial artery stenosis. Cochrane Database Syst Rev 2006;3:CD004133

   PubMed
9. 9.↵
   1. Nahab F,
   2. Lynn MJ,
   3. Kasner SE,
   4. et al

   . Risk factors associated with major cerebrovascular complications after intracranial stenting. Neurology 2009;72:2014–19

   Abstract/FREE Full Text
10. 10.↵
    1. Jiang WJ,
    2. Xu XT,
    3. Du B,
    4. et al

    . Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis. Neurology 2007;68:420–26

    Abstract/FREE Full Text
11. 11.↵
    1. Kurre W,
    2. Berkefeld J,
    3. Brassel F,
    4. et al

    . In-hospital complication rates after stent treatment of 388 symptomatic intracranial stenoses: results from the INTRASTENT Multicentric Registry. Stroke 2010;41:494–98

    Abstract/FREE Full Text
12. 12.↵
    1. Jarvis AL,
    2. Lynn MJ,
    3. Alexander MJ,
    4. et al

    . Outcome of patients with 50–99% intracranial stenosis and TIA or stroke on antithrombotic therapy treated medically vs stenting. In: Proceedings of the 60th Annual Meeting of the American Academy of Neurology. Chicago, Illinois; April 12–19, 2008
13. 13.↵
    1. Samaniego EA,
    2. Hetzel S,
    3. Thirunarayanan S,
    4. et al

    . Outcome of symptomatic intracranial atherosclerotic disease. Stroke 2009;40:2983–87

    Abstract/FREE Full Text
14. 14.↵
    1. Zaidat OO

    . Periprocedural management of patients with endovascular treatment of intracranial atherosclerotic disease. J Neuroimaging 2009;19(suppl 1):35S–38S

    CrossRefPubMed
15. 15.↵
    1. Schumacher HC,
    2. Meyers PM,
    3. Higashida RT,
    4. et al

    . Reporting standards for angioplasty and stent-assisted angioplasty for intracranial atherosclerosis. Stroke 2009;40:e348–65

    CrossRef
16. 16.↵
    1. Qureshi AI,
    2. Feldmann E,
    3. Gomez CR,
    4. et al

    . Consensus conference on intracranial atherosclerotic disease: rationale, methodology, and results. J Neuroimaging 2009;19(suppl 1):1S–10S

    CrossRef
17. 17.↵
    1. Qureshi AI,
    2. Feldmann E,
    3. Gomez CR,
    4. et al

    . Intracranial atherosclerotic disease: an update. Ann Neurol 2009;66:730–38

    CrossRefPubMed
18. 18.↵
    1. Higashida RT,
    2. Meyers PM,
    3. Connors JJ,
    4. et al

    . Intracranial angioplasty and stenting for cerebral atherosclerosis: a position statement of the American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology, and the American Society of Neuroradiology. J Vasc Interv Radiol 2005;16:1281–85

    PubMed
19. 19.↵
    1. Sacco RL,
    2. Adams R,
    3. Albers G,
    4. et al

    . Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke—co-sponsored by the Council on Cardiovascular Radiology and Intervention. The American Academy of Neurology affirms the value of this guideline. Circulation 2006;113:e409–49
20. 20.↵
    1. Rasmussen PA

    . The evolution and role of endovascular therapy for the treatment of intracranial atherosclerotic disease. J Neuroimaging 2009;19(suppl 1):30S–34S

    CrossRefPubMed
21. 21.↵
    1. Gomez CR,
    2. Qureshi AI

    . Medical treatment of patients with intracranial atherosclerotic disease. J Neuroimaging 2009;19(suppl 1):25S–29S

    CrossRefPubMed
22. 22.↵
    1. Mazighi M,
    2. Tanasescu R,
    3. Ducrocq X,
    4. et al

    . Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology 2006;66:1187–91

    Abstract/FREE Full Text
23. 23.↵
    1. Wong KS,
    2. Chen C,
    3. Ng PW,
    4. et al

    . Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study. Lancet Neurol 2007;6:407–13

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Famakin BM,
    2. Chimowitz MI,
    3. Lynn MJ,
    4. et al

    . Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis. Stroke 2009;40:1999–2003

    Abstract/FREE Full Text
25. 25.↵
    1. Bendszus M,
    2. Stoll G

    . Silent cerebral ischaemia: hidden fingerprints of invasive medical procedures. Lancet Neurol 2006; 5: 364–72

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Jiang WJ,
    2. Srivastava T,
    3. Gao F,
    4. et al

    . Perforator stroke after elective stenting of symptomatic intracranial stenosis. Neurology 2006;66:1868–72

    Abstract/FREE Full Text
27. 27.↵
    1. Leung TW,
    2. Yu SC,
    3. Lam WW,
    4. et al

    . Would self-expanding stent occlude middle cerebral artery perforators? Stroke 2009;40:1910–12

    Abstract/FREE Full Text
28. 28.↵
    1. Levy EI,
    2. Turk AS,
    3. Albuquerque FC,
    4. et al

    . Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery 2007;61:644–50, discussion 650–51

    PubMedWeb of Science
29. 29.↵
    1. Zaidat OO,
    2. Klucznik R,
    3. Alexander MJ,
    4. et al

    . The NIH registry on use of the Wingspan stent for symptomatic 70–99% intracranial arterial stenosis. Neurology 2008;70:1518–24

    Abstract/FREE Full Text